Nonpharmacologic treatments, such as cognitive behavioral therapy, help reduce sleep disorders in patients with multiple sclerosis.

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

In multiple sclerosis, the ability of clinicians to provide a prognosis for a patient and the design and interpretation of clinical trials both rely heavily on prognostic factors identified from ...

Objectives Smoking is a well-established risk factor that exacerbates multiple sclerosis (MS) progression and increases disease activity. Smoking cessation promotion practices of MS clinicians are not ...

A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co. (MSD) has just been launched in the US and Canada: ‘Never Miss ...

Background Fatigue is a disabling symptom of multiple sclerosis (MS). The lack of effective therapeutics has promoted the development of cognitive behavioural therapy (CBT)-based fatigue management ...